FMII
BPMC

Farmers & Merchants Investments Inc’s Blueprint Medicines BPMC Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$8.85K – 1732
2025
Q1 		$8.85K Hold
100
– – ﹤0.01% 724
2024
Q4 		$8.72K Hold
100
– – ﹤0.01% 713
2024
Q3 		$9.25K Hold
100
– – ﹤0.01% 719
2024
Q2 		$10.8K Hold
100
– – ﹤0.01% 678
2024
Q1 		$9.49K Hold
100
– – ﹤0.01% 653
2023
Q4 		$9.22K Hold
100
– – ﹤0.01% 651
2023
Q3 		$5.02K Hold
100
– – ﹤0.01% 733
2023
Q2 		$6.32K Hold
100
– – ﹤0.01% 721
2023
Q1 		$4.5K Hold
100
– – ﹤0.01% 747
2022
Q4 		$4.38K Hold
100
– – ﹤0.01% 786
2022
Q3 		$7K Sell
100
-74
-43% -$4.75K ﹤0.01% 685
2022
Q2 		$9K Hold
174
– – ﹤0.01% 711
2022
Q1 		$11K Hold
174
– – ﹤0.01% 707
2021
Q4 		$19K Sell
174
-41
-19% -$4.29K ﹤0.01% 597
2021
Q3 		$22K Sell
215
-36
-14% -$3.35K ﹤0.01% 533
2021
Q2 		$22K Buy
251
+50
+25% +$4.58K ﹤0.01% 467
2021
Q1 		$20K Buy
201
+25
+14% +$2.5K ﹤0.01% 462
2020
Q4 		$20K Sell
176
-25
-12% -$2.63K ﹤0.01% 454
2020
Q3 		$19K Hold
201
– – ﹤0.01% 434
2020
Q2 		$16K Buy
201
+101
+101% +$6.83K ﹤0.01% 452
2020
Q1 		$6K Hold
100
– – ﹤0.01% 590
2019
Q4 		$8K Hold
100
– – ﹤0.01% 632
2019
Q3 		$7K Hold
100
– – ﹤0.01% 638
2019
Q2 		$9K Hold
100
– – ﹤0.01% 563
2019
Q1 		$8K Hold
100
– – ﹤0.01% 586
2018
Q4 		$5K Hold
100
– – ﹤0.01% 639
2018
Q3 		$8K Hold
100
– – ﹤0.01% 582
2018
Q2 		$6K Hold
100
– – ﹤0.01% 661
2018
Q1 		$9K Hold
100
– – ﹤0.01% 537
2017
Q4 		$8K Hold
100
– – ﹤0.01% 582
2017
Q3 		$7K Hold
100
– – ﹤0.01% 599
2017
Q2 		$5K Hold
100
– – ﹤0.01% 649
2017
Q1 		$4K Buy
+100
New +$3.58K ﹤0.01% 619

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Farmers & Merchants Investments Inc's BPMC Position: Q2 2025 in Review

Farmers & Merchants Investments Inc sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 100 shares — an estimated $8.85K sold.

Farmers & Merchants Investments Inc first reported a position in BPMC in Q1 2017 and held it in 33 quarters. The position peaked at $22K in Q3 2021. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Farmers & Merchants Investments Inc reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 100 Blueprint Medicines shares in Q2 2025, an estimated $8.85K.
  • Farmers & Merchants Investments Inc first reported a position in Blueprint Medicines in Q1 2017 and held it in 33 quarters.
  • Farmers & Merchants Investments Inc's Blueprint Medicines position peaked at $22K in Q3 2021.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2025, filed 14 Jul 2025.